- Gibtulio Met 12.5 mg/500 mg Tablet effectively lowers blood sugar levels in patients with Type 2 diabetes.
- This formulation combines Empagliflozin and Metformin for enhanced glycemic control.
- Gibtulio Met 12.5 mg/500 mg Tablet aids in weight management, making it suitable for overweight diabetic patients.
- It reduces the risk of cardiovascular complications associated with diabetes.
- Gibtulio Met 12.5 mg/500 mg Tablet helps improve insulin sensitivity, facilitating better glucose uptake by cells.
- This medication can prevent complications arising from prolonged high blood sugar levels.
- Gibtulio Met 12.5 mg/500 mg Tablet is beneficial for patients who have not achieved adequate control with Metformin alone.
- It promotes urinary glucose excretion, which helps in managing overall blood glucose levels.
- Gibtulio Met 12.5 mg/500 mg Tablet is often prescribed alongside lifestyle modifications for optimal results.
- This therapy can help reduce the frequency of hypoglycemic episodes when used appropriately.
- Gibtulio Met 12.5 mg/500 mg Tablet supports better overall metabolic health in diabetic patients.
- It is suitable for adults with Type 2 diabetes who require combination therapy for effective management.
Gibtulio Met 12.5 mg/500 mg Tablet - Strip of 10
Compositions : Empagliflozin 12.5mg + Metformin 500mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Lupin Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Gibtulio Met 12.5 mg/500 mg Tablet is a pharmaceutical formulation designed specifically for the management of Type 2 diabetes mellitus. This medication combines two active ingredients, Empagliflozin and Metformin, to effectively control blood sugar levels in patients with this condition. The key composition of Gibtulio Met 12.5 mg/500 mg Tablet includes 12.5 mg of Empagliflozin and 500 mg of Metformin, making it a potent combination therapy for diabetes management. The primary purpose of Gibtulio Met 12.5 mg/500 mg Tablet is to lower blood glucose levels by utilizing the synergistic effects of its components. Empagliflozin works by promoting the excretion of excess glucose through urine, while Metformin decreases glucose production in the liver and enhances insulin sensitivity. This dual action not only helps in controlling blood sugar but also offers therapeutic advantages such as weight management and cardiovascular protection. As a member of the antidiabetic medication category, Gibtulio Met 12.5 mg/500 mg Tablet is prescribed to patients who require more than just Metformin alone for optimal glycemic control. The formulation is particularly beneficial for those who are at risk of cardiovascular events, as it has been shown to reduce the incidence of heart attacks and heart failure. Overall, Gibtulio Met 12.5 mg/500 mg Tablet represents a comprehensive approach to diabetes treatment, addressing both hyperglycemia and associated health risks.
Product Details
Gibtulio Met 12.5 mg/500 mg Tablet operates through a dual mechanism involving its two active ingredients. Empagliflozin facilitates the removal of excess glucose via urine, while Metformin reduces glucose production in the liver and enhances insulin sensitivity.
- Empagliflozin inhibits sodium-glucose co-transporter 2 (SGLT2), leading to increased glucose excretion in urine.
- Metformin decreases hepatic glucose output and improves peripheral glucose uptake.
- Together, these actions result in lower blood glucose levels and improved glycemic control.
- The combination also aids in weight loss, which is beneficial for many Type 2 diabetes patients.
- Gibtulio Met 12.5 mg/500 mg Tablet may also have positive effects on cardiovascular health by reducing the risk of heart-related issues.
- Gibtulio Met 12.5 mg/500 mg Tablet should be taken orally with food to minimize gastrointestinal discomfort.
- The recommended dosage is typically one tablet daily, but this may vary based on individual patient needs.
- It is important to take the medication at the same time each day to maintain consistent blood sugar control.
- The duration of treatment with Gibtulio Met 12.5 mg/500 mg Tablet should be determined by a healthcare provider based on patient response and blood sugar levels.
- Patients should not exceed the prescribed dosage without consulting their doctor.
- Regular monitoring of blood glucose levels is essential while using this medication.
- If a dose is missed, it should be taken as soon as remembered unless it is close to the time for the next dose.
- Consult a healthcare professional for any adjustments in dosage or treatment duration.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Gibtulio Met 12.5 mg/500 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication.
- Avoid skipping meals to prevent fluctuations in blood sugar levels while on this therapy.
- Stay hydrated by drinking plenty of water throughout the day to counteract potential dehydration effects.
- Monitor blood sugar levels regularly to ensure optimal management while using Gibtulio Met 12.5 mg/500 mg Tablet.
Safety Advice
Side Effects
- Common side effects of Gibtulio Met 12.5 mg/500 mg Tablet include nausea and vomiting.
- Patients may experience urinary tract infections or genital fungal infections while on this medication.
- Flatulence and dyslipidemia are also reported side effects associated with this therapy.
- Polyuria (increased urination) can occur due to the action of Empagliflozin.
- Serious side effects may include dehydration or severe allergic reactions; seek medical attention if these occur.
- Monitor for symptoms of low blood sugar, especially when combined with other antidiabetic medications.
- If persistent side effects are experienced, consult a healthcare provider for further evaluation.
Precautions and Warnings
- Gibtulio Met 12.5 mg/500 mg Tablet should not be used by individuals with a known allergy to its components.
- Patients with severe kidney impairment should avoid this medication due to potential risks.
- Caution is advised when using this therapy during pregnancy or breastfeeding; consult a doctor before use.
- Avoid alcohol consumption while taking Gibtulio Met 12.5 mg/500 mg Tablet as it may increase the risk of hypoglycemia.
- Regular monitoring of kidney function is recommended during treatment with this medication.
- Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.
- If experiencing symptoms such as excessive thirst or fatigue, seek medical advice promptly.
FAQs
Gibtulio Met 12.5 mg/500 mg Tablet is primarily used for managing Type 2 diabetes mellitus by controlling blood sugar levels.
2. How should I take Gibtulio Met 12.5 mg/500 mg Tablet?
This medication should be taken orally with food to minimize gastrointestinal discomfort and should be taken at the same time each day.
3. What are the common side effects of Gibtulio Met 12.5 mg/500 mg Tablet?
Common side effects include nausea, vomiting, urinary tract infections, and increased urination.
4. Can I drink alcohol while taking Gibtulio Met 12.5 mg/500 mg Tablet?
It is advisable to avoid alcohol consumption as it may increase the risk of low blood sugar.
5. Who should not use Gibtulio Met 12.5 mg/500 mg Tablet?
Individuals with severe kidney impairment or known allergies to its components should avoid using this medication.
6. How does Gibtulio Met 12.5 mg/500 mg Tablet work?
The tablet combines Empagliflozin and Metformin; Empagliflozin promotes glucose excretion through urine while Metformin reduces liver glucose production.
7. What precautions should I take while using Gibtulio Met 12.5 mg/500 mg Tablet?
Regular monitoring of kidney function and blood sugar levels is essential; consult your doctor about any other medications you are taking.
Instructions
Directions for Use
Storage and Disposal
- Store in a cool, dry place below 30°C, away from direct sunlight and moisture.
- Keep out of reach of children.
- Dispose of unused medicine as per local regulations. Do not flush into drains or throw in household waste.
More Information
| SKU | 401278 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Gibtulio Met 12.5 mg/500 mg Tablet is a pharmaceutical formulation designed specifically for the management of Type 2 diabetes mellitus. This medication combines two active ingredients, Empagliflozin and Metformin, to effectively control blood sugar levels in patients with this condition. The key composition of Gibtulio Met 12.5 mg/500 mg Tablet includes 12.5 mg of Empagliflozin and 500 mg of Metformin, making it a potent combination therapy for diabetes management. The primary purpose of Gibtulio Met 12.5 mg/500 mg Tablet is to lower blood glucose levels by utilizing the synergistic effects of its components. Empagliflozin works by promoting the excretion of excess glucose through urine, while Metformin decreases glucose production in the liver and enhances insulin sensitivity. This dual action not only helps in controlling blood sugar but also offers therapeutic advantages such as weight management and cardiovascular protection. As a member of the antidiabetic medication category, Gibtulio Met 12.5 mg/500 mg Tablet is prescribed to patients who require more than just Metformin alone for optimal glycemic control. The formulation is particularly beneficial for those who are at risk of cardiovascular events, as it has been shown to reduce the incidence of heart attacks and heart failure. Overall, Gibtulio Met 12.5 mg/500 mg Tablet represents a comprehensive approach to diabetes treatment, addressing both hyperglycemia and associated health risks.
- Gibtulio Met 12.5 mg/500 mg Tablet effectively lowers blood sugar levels in patients with Type 2 diabetes.
- This formulation combines Empagliflozin and Metformin for enhanced glycemic control.
- Gibtulio Met 12.5 mg/500 mg Tablet aids in weight management, making it suitable for overweight diabetic patients.
- It reduces the risk of cardiovascular complications associated with diabetes.
- Gibtulio Met 12.5 mg/500 mg Tablet helps improve insulin sensitivity, facilitating better glucose uptake by cells.
- This medication can prevent complications arising from prolonged high blood sugar levels.
- Gibtulio Met 12.5 mg/500 mg Tablet is beneficial for patients who have not achieved adequate control with Metformin alone.
- It promotes urinary glucose excretion, which helps in managing overall blood glucose levels.
- Gibtulio Met 12.5 mg/500 mg Tablet is often prescribed alongside lifestyle modifications for optimal results.
- This therapy can help reduce the frequency of hypoglycemic episodes when used appropriately.
- Gibtulio Met 12.5 mg/500 mg Tablet supports better overall metabolic health in diabetic patients.
- It is suitable for adults with Type 2 diabetes who require combination therapy for effective management.
Gibtulio Met 12.5 mg/500 mg Tablet operates through a dual mechanism involving its two active ingredients. Empagliflozin facilitates the removal of excess glucose via urine, while Metformin reduces glucose production in the liver and enhances insulin sensitivity.
- Empagliflozin inhibits sodium-glucose co-transporter 2 (SGLT2), leading to increased glucose excretion in urine.
- Metformin decreases hepatic glucose output and improves peripheral glucose uptake.
- Together, these actions result in lower blood glucose levels and improved glycemic control.
- The combination also aids in weight loss, which is beneficial for many Type 2 diabetes patients.
- Gibtulio Met 12.5 mg/500 mg Tablet may also have positive effects on cardiovascular health by reducing the risk of heart-related issues.
- Gibtulio Met 12.5 mg/500 mg Tablet should be taken orally with food to minimize gastrointestinal discomfort.
- The recommended dosage is typically one tablet daily, but this may vary based on individual patient needs.
- It is important to take the medication at the same time each day to maintain consistent blood sugar control.
- The duration of treatment with Gibtulio Met 12.5 mg/500 mg Tablet should be determined by a healthcare provider based on patient response and blood sugar levels.
- Patients should not exceed the prescribed dosage without consulting their doctor.
- Regular monitoring of blood glucose levels is essential while using this medication.
- If a dose is missed, it should be taken as soon as remembered unless it is close to the time for the next dose.
- Consult a healthcare professional for any adjustments in dosage or treatment duration.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Gibtulio Met 12.5 mg/500 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication.
- Avoid skipping meals to prevent fluctuations in blood sugar levels while on this therapy.
- Stay hydrated by drinking plenty of water throughout the day to counteract potential dehydration effects.
- Monitor blood sugar levels regularly to ensure optimal management while using Gibtulio Met 12.5 mg/500 mg Tablet.
Side Effects
- Common side effects of Gibtulio Met 12.5 mg/500 mg Tablet include nausea and vomiting.
- Patients may experience urinary tract infections or genital fungal infections while on this medication.
- Flatulence and dyslipidemia are also reported side effects associated with this therapy.
- Polyuria (increased urination) can occur due to the action of Empagliflozin.
- Serious side effects may include dehydration or severe allergic reactions; seek medical attention if these occur.
- Monitor for symptoms of low blood sugar, especially when combined with other antidiabetic medications.
- If persistent side effects are experienced, consult a healthcare provider for further evaluation.
Precautions and Warnings
- Gibtulio Met 12.5 mg/500 mg Tablet should not be used by individuals with a known allergy to its components.
- Patients with severe kidney impairment should avoid this medication due to potential risks.
- Caution is advised when using this therapy during pregnancy or breastfeeding; consult a doctor before use.
- Avoid alcohol consumption while taking Gibtulio Met 12.5 mg/500 mg Tablet as it may increase the risk of hypoglycemia.
- Regular monitoring of kidney function is recommended during treatment with this medication.
- Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.
- If experiencing symptoms such as excessive thirst or fatigue, seek medical advice promptly.
Gibtulio Met 12.5 mg/500 mg Tablet is primarily used for managing Type 2 diabetes mellitus by controlling blood sugar levels.
2. How should I take Gibtulio Met 12.5 mg/500 mg Tablet?
This medication should be taken orally with food to minimize gastrointestinal discomfort and should be taken at the same time each day.
3. What are the common side effects of Gibtulio Met 12.5 mg/500 mg Tablet?
Common side effects include nausea, vomiting, urinary tract infections, and increased urination.
4. Can I drink alcohol while taking Gibtulio Met 12.5 mg/500 mg Tablet?
It is advisable to avoid alcohol consumption as it may increase the risk of low blood sugar.
5. Who should not use Gibtulio Met 12.5 mg/500 mg Tablet?
Individuals with severe kidney impairment or known allergies to its components should avoid using this medication.
6. How does Gibtulio Met 12.5 mg/500 mg Tablet work?
The tablet combines Empagliflozin and Metformin; Empagliflozin promotes glucose excretion through urine while Metformin reduces liver glucose production.
7. What precautions should I take while using Gibtulio Met 12.5 mg/500 mg Tablet?
Regular monitoring of kidney function and blood sugar levels is essential; consult your doctor about any other medications you are taking.
Directions for Use
Storage and Disposal
- Store in a cool, dry place below 30°C, away from direct sunlight and moisture.
- Keep out of reach of children.
- Dispose of unused medicine as per local regulations. Do not flush into drains or throw in household waste.
| SKU | 401278 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account